Metraipolis › archive › dc_98f4eee52256

Camelid-Derived Nanobodies Targeting Human Epidermal Growth Factor Receptor: Screening, Expression, and Functional Validation — Europe PMC PMID:41874024

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41874024
DOI
10.3390/antib15020019
License (as archived)
solo-consultazione
Archived
2026-11-05T08:21:52.052Z
SHA-256 of the archived text
92d10368768dac4da4ab34c6f0d386dfda7b1bc51c6e88be5a99fdca10f65931
Stable URL of this page
https://metraipolis.com/documento/dc_98f4eee52256

How to cite

Camelid-Derived Nanobodies Targeting Human Epidermal Growth Factor Receptor: Screening, Expression, and Functional Validation — Europe PMC PMID:41874024 — Europe PMC (en), https://europepmc.org/article/MED/41874024 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_98f4eee52256 (Metraipolis archive dc_98f4eee52256, sha256 92d10368768dac4da4ab34c6f0d386dfda7b1bc51c6e88be5a99fdca10f65931)
BibTeX
@misc{dc98f4eee52256,
  title = {Camelid-Derived Nanobodies Targeting Human Epidermal Growth Factor Receptor: Screening, Expression, and Functional Validation — Europe PMC PMID:41874024},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41874024},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_98f4eee52256; sha256 92d10368768dac4da4ab34c6f0d386dfda7b1bc51c6e88be5a99fdca10f65931},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41874024. Agents can read the archived copy with the MCP tool read_document.